Publications by authors named "Elizabeth Renzoni"

Claim this Profile
P
Progressive pulmonary fibrosis: an expert group consensus statement.
Sujeet K Rajan, Vincent Cottin, Raja Dhar, Sonye Danoff, Kevin R Flaherty, Elizabeth Renzoni

Eur Respir J· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of Lung Disease Associated with Connective Tissue Disease.
Emily C Bartlett, Elizabeth A Renzoni, Nishanth Sivarasan, Sujal R Desai

Semin Respir Crit Care Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality.
Eliza Tsitoura, Athina Trachalaki, Eirini Vasarmidi, Semeli Mastrodemou, George A Margaritopoulos, Elizabeth Renzoni

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?
Meena Kalluri, Fabrizio Luppi, Ada Vancheri, Carlo Vancheri, Elisabetta Balestro, Elizabeth Renzoni

Eur Respir Rev· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying causation in hypersensitivity pneumonitis: a British perspective.
Christopher Michael Barber, P Sherwood Burge, Jo R Feary, Helen Parfrey, Elizabeth A Renzoni

BMJ Open Respir Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The King's Brief Interstitial Lung Disease (KBILD) questionnaire: an updated minimal clinically important difference.
Aish Sinha, Amit Suresh Patel, Richard J Siegert, Sabrina Bajwah, Toby M Maher, Elizabeth A Renzoni

BMJ Open Respir Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent.
Rachele Invernizzi, Joseph Barnett, Bhavin Rawal, Arjun Nair, Poonam Ghai, Elizabeth R Renzoni

Eur Respir J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential impact of azithromycin in idiopathic pulmonary fibrosis.
Claudio Macaluso, Joaquín Maritano Furcada, Omamah Alzaher, Ritesh Chaube, Felix Chua, Elizabeth A Renzoni

Eur Respir J· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice.
Sophie V Fletcher, Mark G Jones, Elizabeth A Renzoni, Helen Parfrey, Rachel K Hoyles

ERJ Open Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia.
Tamera J Corte, Gregory J Keir, Konstantinos Dimopoulos, Luke Howard, Paul A Corris, Elizabeth A Renzoni

Am J Respir Crit Care Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alveolar proteinosis with hypersensitivity pneumonitis: a new clinical phenotype.
Hema Verma, Andrew G Nicholson, Keith M Kerr, Owen J Dempsey, Allen R Gibbs, Elizabeth A Renzoni

Respirology· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin axis polymorphisms in patients with scleroderma.
Carmen Fonseca, Elizabeth Renzoni, Piersante Sestini, Panagiotis Pantelidis, Anna Lagan

Arthritis Rheum· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis